Company page

Crispr Therapeutics Ag

Crispr Therapeutics AG is a public biotechnology company traded under the ticker CRSP in the American market. The company focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing technology. As of now, Crispr Therapeutics has a market capitalization of approximately $5.22 billion.